# Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast Cancer

> **NCT02468739** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 206 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Ganglioside-monosialic acid
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02468739
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2021-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02468739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02468739, "Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast Cancer". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT02468739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*